Atlas Venture Fund X, L.P. - Aug 14, 2023 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Role
10%+ Owner
Signature
Atlas Venture Fund X, L.P., By: Atlas Venture Associates X, L.P., its general partner, By: Atlas Venture Associates X, LLC, its general partner, By: Ommer Chohan, Chief Financial Officer /s/ Ommer Chohan
Stock symbol
IRON
Transactions as of
Aug 14, 2023
Transactions value $
-$18,845,200
Form type
4
Date filed
8/16/2023, 06:55 PM
Previous filing
Jan 13, 2023
Next filing
Sep 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRON Common Stock Sale -$3.9M -75K -3.35% $52.00 2.16M Aug 14, 2023 Direct F1, F2
transaction IRON Common Stock Sale -$5.19M -98K -4.53% $53.00 2.06M Aug 14, 2023 Direct F2
transaction IRON Common Stock Sale -$110K -2K -0.1% $54.80 2.06M Aug 14, 2023 Direct F2, F3
transaction IRON Common Stock Sale -$5.82M -111K -5.39% $52.40 1.95M Aug 15, 2023 Direct F2
transaction IRON Common Stock Sale -$3.82M -72.9K -7.64% $52.40 882K Aug 15, 2023 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.00 to $52.22 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3).
F2 These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas X"). Atlas Venture Associates X, L.P. ("Associates X") is the general partner of Atlas X. Atlas Venture Associates X, LLC ("Associates X LLC") is the general partner of Associates X. Each of Associates X and Associates X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas X, except to the extent of its pecuniary interest therein, if any.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.48 to $54.94 inclusive.
F4 These shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Opportunity I"). Atlas Venture Associates Opportunity I, L.P. ("Associates I") is the general partner of Atlas Opportunity I. Atlas Venture Associates Opportunity I, LLC ("Associates I LLC") is the general partner of Associates I. Each of Associates I and Associates I LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Opportunity I, except to the extent of its pecuniary interest therein, if any.